A case-control study of asthma death and life-threatening attack: Their possible relationship with prescribed drug therapy in Japan

Journal of Epidemiology

Volumn 12, Issue 3, 2002, Pages 223-228

  Tanihara, Shinichi ^a   Nakamura, Yosikazu ^b   Matsui, Takehiko ^c   Nishima, Sankei ^d  

^a SHIMANE UNIVERSITY   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c Department of Dentistry Oral surgery   (Japan)

^d FUKUOKA NATIONAL HOSPITAL   (Japan)

Author keywords

Asthma; Asthma death; Life threatening attack; Metered dose inhaler; 2 agonist

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; ASTHMA; CASE CONTROL STUDY; CHILD; CLASSIFICATION; FEMALE; HOSPITALIZATION; HUMAN; INFANT; JAPAN; MALE; MORTALITY; PRESCHOOL CHILD; RISK FACTOR;

ADOLESCENT; ADRENERGIC BETA-AGONISTS; ADULT; AGE DISTRIBUTION; ASTHMA; BRONCHODILATOR AGENTS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; JAPAN; MALE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 0036562761     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.12.223     Document Type: Article

References (20)

1. Speizer FE, Doll R, Heaf P. Observations on recent increase in mortality from asthma. Br Med J, 1968; 1: 335-339.
2. Inman WH, Adelstein AM. Rise and fall of asthma mortality in England and Wales in relation to use of pressurised aerosols. Lancet, 1969; 2: 279-285.
3. Mitsui S. The trends of asthma death in Japan. Arerugi No Rinsho, 1985; 5: 876-882 (in Japanese).
4. Crane J, Pearce N, Flau A et al. Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet, 1989; 1: 917-922.
5. Pearce N, Grainger J, Atkinson M et al. Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. Thorax, 1990; 45: 170-175.
6. Grainger J, Woodman K, Pearce N et al. Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. Thorax, 1991; 46: 105-111.
7. Burgess C, Pearce N, Thiruchelvam R et al. Prescribed drug therapy and near-fatal asthma attacks. Eur Respir J, 1994; 7: 498-503.
8. Garrett JE, Lanes SF, Kolbe J, Rea HH. Risk of severe life threatening asthma and β-agonist type: an example of confounding by severity. Thorax, 1996; 51: 1093-1099.
9. Suissa S, Ernst P, Boivin JF et al. A cohort analysis of excess mortality in asthma and the use of inhaled β-agonists. Am J Respir Crit Care Med, 1994; 149: 604-610.
10. Rea HH, Garrett JE, Lanes SF, Birmann BM, Kolbe J. The association between asthma drugs and severe life-threatening attacks. Chest, 1996; 110: 1446-451.
11. Beasley R, Burgess C, Pearce N, Woodman K, Crane J. Confounding by severity does not explain the association between fenoterol and asthma death. Clin Exp Allergy, 1994; 24: 660-668.
12. Anonymous. International consensus report on diagnosis and treatment of asthma. National Heart, Lung, and Blood Institute, National Institutes of Health. Bethesda, Maryland 20892. Publication no. 92-3091, March 1992. Eur Respir J, 1992; 5: 601-641.
13. Crane J, Pearce N, Burgess C, Woodman K, Robson B, Beasley R. Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. Int J Epidemiol, 1992; 21: 737-744.
14. Williams C, Grassland L, Finnerty J et al. Case-control study of salmeterol and near-fatal attacks of asthma. Thorax, 1998; 53: 7-13.
15. Mullen M, Mullen B, Carey M. The association between β-agonist use and death from asthma. A meta-analytic integration of case-control studies. JAMA, 1993; 270: 1842-1845.
16. Spitzer WO, Suissa S, Ernst P et al. The use of β-agonists and the risk of death and near death from asthma. N Engl J Med, 1992; 326: 501-506.
17. Woodman K, Pearce N, Beasley R, Burgess C, Crane J. Albuterol and deaths from asthma in New Zealand from 1969 to 1976: a case-control study. Clin Pharmacol Ther, 1992; 51: 566-571.
18. Ernst P, Habbick B, Suissa S et al. Is the association between inhaled beta-agonist use and life-threatening asthma because of confounding by severity? Am Rev Respir Dis, 1993; 148: 75-79.
19. Cerveri I, Locatelli F, Zoia MC, Corsico A, Accordini S, de Marco R. International variations in asthma treatment compliance: the results of the European Community Respiratory Health Survey (ECRHS). Eur Respir J, 1999; 14: 288-294.
20. Rothman KJ, Greenland S. Approaches to statistical analysis. In; Rothman KJ, Greenland S, eds. Modern epidemiology, Lippincott-Raven, Philadelphia, 1998: 183-199.